Related Experiment Video
Updated: Jun 3, 2025
07:40
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
1.1K
Hydroxytyrosol: A Promising Therapeutic Agent for Mitigating Inflammation and Apoptosis.
Wafa Ali Batarfi1,2, Mohd Heikal Mohd Yunus1, Adila A Hamid1
1Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob Latiff, Bandar Tun Razak, Kuala Lumpur 56000, Malaysia.
Pharmaceutics
|January 8, 2025
Summary
Hydroxytyrosol (HT) shows promise in managing inflammation and apoptosis, crucial in chronic diseases. This natural compound offers potential therapeutic benefits for cardiovascular, neurological, and osteoarthritis conditions.
Area of Science:
- Biochemistry
- Pharmacology
- Molecular Biology
Background:
- Inflammation and apoptosis are key processes in chronic diseases like cardiovascular and neurological conditions.
- Targeting these mechanisms offers novel therapeutic strategies for improved patient outcomes.
Purpose of the Study:
- To review the anti-inflammatory and antiapoptotic effects of Hydroxytyrosol (HT).
- To explore the mechanisms underlying HT's therapeutic potential.
- To assess HT's suitability as a bioactive ingredient in pharmaceuticals.
Main Methods:
- Comprehensive review of in vitro and in vivo studies.
- Analysis of research on Hydroxytyrosol's biological activities.
- Examination of scientific literature on inflammation and apoptosis.
Main Results:
- Hydroxytyrosol (HT) exhibits significant anti-inflammatory and antiapoptotic properties.
- HT demonstrates potential in mitigating chronic disease progression.
- Evidence supports HT's role in regulating cellular stress pathways.
Conclusions:
- Hydroxytyrosol (HT) is a promising therapeutic agent for conditions involving inflammation and apoptosis.
- HT's antioxidant and regulatory functions suggest its value in pharmaceutical development.
- Further research into HT is recommended for its application in treating chronic diseases.
